Blue-Chip

Speculative Bet on This NYSE-Listed Industrial Stock – LDOS

January 14, 2022 | Team Kalkine
Speculative Bet on This NYSE-Listed Industrial Stock – LDOS

Leidos Holdings, Inc.

LDOS Details

Leidos Holdings, Inc. (NYSE: LDOS) is a scientific, engineering, and information technology company that primarily serves government entities and agencies in the military, intelligence, civil, and healthcare sectors in the United States and worldwide. LDOS leverages its five technical core capabilities to provide customers with domain-specific and cross-market innovative products: digital modernization, cyber operations, mission software systems, integrated systems, and mission operations. As of January 13, 2022, the company's market capitalization stood at USD 12.60 billion.

 

Latest News:

  • Strategic Investment: On January 06, 2022, LDOS announced its strategic investment in HawkEye 360, the commercial provider of space-based radio frequency (RF) data and analytics. The investment is intended to achieve transformational growth in data and analytical services, where both the companies will share information and pool resources.
  • Key Commercial Contract: In support of the US Department of Homeland Security (DHS) Cybersecurity and Infrastructure Security Agency (CISA), LDOS was granted the Priority Services Scientific, Engineering, and Technical Assistance (PS-SETA) prime contract on December 14, 2021. The competitive single-award hybrid contract includes the cost-plus-fixed-fee, firm-fixed-price, and reimbursable cost line items. It has a nine-month performance period as well as four one-year options. The contract will be worth around USD 61.5 million if all options are exercised.

Q3FY21 Results:

  • Improvement in Revenues: LDOS reported a 7.43% increase in revenues to USD 3.48 billion in Q3FY21 (ended October 01, 2021) from USD 3.24 billion in Q3FY20 (ended October 02, 2020), driven by growth in all the segments.
  • Net Income Growth: The Q3FY21 net income was USD 205 million vs. USD 163 million reported in Q3FY20, representing an EPS (diluted) of USD 1.43.
  • Robust Balance Sheet: The company exited the quarter with a cash balance of USD 587 million and total debt of 5.10 billion.

Key Risks:

  • Customer Concentration Risk: In Q3FY21 and 9MFY21, contracts with the US government accounted for 88% and 87% of total revenues. Due to macroeconomic or political factors, any decline in business from government departments/organizations or any changes in federal budgets could impair the company's financial health and operations.

Outlook:

  • Revenue & EPS Estimate: LDOS expects to generate USD 13.7 – 13.9 billion in total revenues in FY21, with non-GAAP diluted EPS ranging from USD 6.55 – 6.75. The adjusted EBITDA margin for the year is estimated to range between 10.9% – 11.1%.

 FY21 Guidance (Source: Q3FY21 Earnings Presentation, November 02, 2021)

 

Valuation Methodology: EV/EBITDA Multiple Based Relative Valuation

(Analysis by Kalkine Group)

  • % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

LDOS Daily Technical Chart (Source: REFINITIV)

Stock Recommendation:

LDOS's stock price fell 12.31% in the past six months and is currently leaning towards the lower end of its 52-week range of USD 82.75 to USD 113.75. The stock is currently trading between its 50 and 200 DMA levels, and its RSI Index is at 58.32. We have valued the stock using the EV/EBITDA multiple-based relative valuation methodology and arrived at a target price of USD 113.09.

Considering the correction in the stock price, strategic investments, commercial contracts, positive outlook, and associated risks, we recommend a "Buy" rating on the stock at the closing price of USD 92.48, up 2.97% as of January 13, 2022.

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.


Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.